Comparison of human chorionic gonadotropin and gonadotropin-releasing hormone agonist for final oocyte maturation in oocyte donor cycles
- 31 July 2007
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 88 (1), 237-239
- https://doi.org/10.1016/j.fertnstert.2006.11.069
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Serum inhibin A, VEGF and TNFα levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trialHuman Reproduction, 2006
- GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysisHuman Reproduction Update, 2005
- Effects of the ovulatory serum concentration of human chorionic gonadotropin on the incidence of ovarian hyperstimulation syndrome and success rates for in vitro fertilizationFertility and Sterility, 2005
- A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonistsHuman Reproduction, 2005
- GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized studyHuman Reproduction, 2005
- Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndromeFertility and Sterility, 2004
- Ovarian hyperstimulation syndromeFertility and Sterility, 2003
- Severe OHSS: Yes, there is a strategy to prevent it!Human Reproduction, 2000
- A case of severe ovarian hyperstimulation in a healthy oocyte donorFertility and Sterility, 1995